Skip to main content
Premium Trial:

Request an Annual Quote

John Maraganore, Greg Lucier, Carl Turza, Mark Stevenson, William Murray, Leonard Klevan

Premium

Alnylam Pharmaceuticals President and Chief Executive Officer John Maraganore and Invitrogen CEO Greg Lucier have been appointed to the board of directors of the Biotechnology Industry Organization.

Maraganore and Lucier will serve three-year terms.


Sigma-Aldrich has named Carl Turza chief information officer, effective May 1.

Turza has worked at W.W. Grainger, AlliedSignal Aerospace, and other "large and complex" organizations, Sigma-Aldrich said. He holds an MBA from the University of Illinois in Chicago and a BA in economics from the University of Illinois in Champaign.


Applied Biosystems announced this week that Mark Stevenson has been appointed president of the firm's molecular biology division. He previously served as president of the firm's applied markets division.

Stevenson succeeds William Murray, who has resigned due to personal reasons.

ABI also announced that Leonard Klevan has replaced Stevenson as president of the applied markets division. Klevan had joined ABI earlier this year as vice president of R&D for applied markets.

Before joining ABI, he was CEO of ReliaGene Technologies. He also is a former president and CEO of MiraiBio, a subsidiary of Hitachi Software Engineering, and had managed technology acquisitions and business development at Life Technologies, which was acquired by Invitrogen in 2000.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.